Re-irradiation of anaplastic meningioma: higher dose and concomitant Bevacizumab may improve progression-free survival.

Radiat Oncol · 2024 · PMC11447990 · PMID 39358739

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

did not reach statistical significanceno p-value reported

A statistical trend for improving progression-free survival did not reach statistical significance with using bevacizumab.

also in 1,573 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.